ECSP982457A - Nuevo producto farmaceutico - Google Patents

Nuevo producto farmaceutico

Info

Publication number
ECSP982457A
ECSP982457A ECSP982457A ECSP982457A EC SP982457 A ECSP982457 A EC SP982457A EC SP982457 A ECSP982457 A EC SP982457A EC SP982457 A ECSP982457 A EC SP982457A
Authority
EC
Ecuador
Prior art keywords
gives
compound
pharmaceutical product
new pharmaceutical
spectrum containing
Prior art date
Application number
Other languages
English (en)
Inventor
Graham Ralph Slater
Paul Jeffrey Westlake
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982457 priority Critical patent/ECSP982457A/es
Publication of ECSP982457A publication Critical patent/ECSP982457A/es

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nuevo producto farmacéutico hidrocloruro de N-[3-[[2-(e,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida, caracterizado porque: (i) contiene agua en la proporción de 1,7 a 2,4 equivalentes molares; y/o (ii) tiene un punto de fusión superior a 145oC y/o (iii) da un espectro infrarrojo que contiene picos a 3510, 3342, 3076, 1665, 1598, 1343, 1330, 1216 y 801 cm-1: y/o (iv) da un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos como se representa sustancialmente en la tabla I; y/o (v) da un patrón de disfracción en polvo de rayos X (XRPD) sustancialmente como se representa en la tabla II; un procedimiento para preparar dicho compuesto, una composición farmacéutica que comprende dicho compuesto, y el uso de dicho compuesto en medicina.
ECSP982457 1998-03-25 1998-03-25 Nuevo producto farmaceutico ECSP982457A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982457 ECSP982457A (es) 1998-03-25 1998-03-25 Nuevo producto farmaceutico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982457 ECSP982457A (es) 1998-03-25 1998-03-25 Nuevo producto farmaceutico

Publications (1)

Publication Number Publication Date
ECSP982457A true ECSP982457A (es) 1999-01-12

Family

ID=42043378

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982457 ECSP982457A (es) 1998-03-25 1998-03-25 Nuevo producto farmaceutico

Country Status (1)

Country Link
EC (1) ECSP982457A (es)

Similar Documents

Publication Publication Date Title
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HUP0300059A3 (en) Quinazoline derivatives, process for their preparation, pharmaceutical compositions containing the compounds and use of the new and known quinazoline derivatives against proliferative disease
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0402338A3 (en) Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
PT1412384E (pt) Formulação estável de glp-1 modificado
HUP0401174A3 (en) Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds
AR035563A1 (es) Polimorfos cristalinos homogeneos del clorhidrato de n - ( 3 - etinilfenil ) - 6 , 7 - bis ( 2 - metoxietoxi ) - 4 quinazolinamina ; composiciones farmaceuticas formuladas con dichos polimorfos; uso de los mismos en la preparacion de dichas composiciones; proceso para la preparacion del polimorfo b
GEP20053530B (en) Tyrosine Kinase Inhibitors, Pharmaceutical Compositions Containing Them and Use Thereof
MY127369A (en) Quinazoline derivatives
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
DE60116761D1 (en) Adamantanderivate
HUP0105113A3 (en) Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
HUP0102039A3 (en) Use of paclitaxel stabilized with albumin for the preparation of pharmaceutical compositions treating solid tumors and the pharmaceutical compositions obtained thereby
YU38802A (sh) Nova kompozicija i njena upotreba
AR021355A1 (es) Derivados de quinolina. procedimiento para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de unmedicamento
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
ZA985392B (en) New derivatives of 2-(iminomethyl) amino-phenyl, their preparation their use as medicaments and the pharmaceutical compositions containing them
GEP20063775B (en) Reconstitutable Parenteral Composition Containing A COX-2 Inhibitor
GB0109122D0 (en) Novel compounds
HUP0301075A3 (en) Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds
HUP0003207A3 (en) Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them
HUP0301784A3 (en) Biphenyl derivatives, of imidazole and benzimidazole the use thereof, process for the preparation of compounds and pharmaceutical compositions containing them
ECSP982457A (es) Nuevo producto farmaceutico